Identification of an immune checkpoint gene signature that accurately predicts prognosis and immunotherapy response in endometrial carcinoma

Shaowen Li; Chunli Dong; Jiayan Chen; Xiaocui Gao; Xiuying Xie; Xin Zhang

doi:doi:10.18632/aging.203189

← Back

Research Paper Volume 13, Issue 12 pp 16696—16712

Identification of an immune checkpoint gene signature that accurately predicts prognosis and immunotherapy response in endometrial carcinoma

Figure 9. Survival analysis of EC patients belonging to different ICG expression subgroups. (A) Kaplan-Meier survival curves show OS of EC patients belonging to high or low IDO1 and TNFRSF14 expression groups. (B) Kaplan-Meier survival curves show OS of EC patients belonging to high or low CD274 and TNFRSF14 expression groups. (C) Kaplan-Meier survival curves show OS of EC patients belonging to high or low CTLA4 and TNFRSF14 expression groups. (D) Kaplan-Meier survival curves show OS of EC patients belonging to IDO1^low TNFRSF14^high and IDO1^low TNFRSF14^low expression groups. (E) Kaplan-Meier survival curves show OS of EC patients belonging to CD274^low TNFRSF14^high and CD274^low TNFRSF14^low expression groups. (F) Kaplan-Meier survival curves show OS of EC patients belonging to CTLA4^low TNFRSF14^high and CTLA4^low TNFRSF14^low expression groups. The abscissa represents survival time, and the ordinate represents overall survival.